Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device

Pennsylvania Hospital, Philadelphia, USA.

OBJECTIVES. This study was performed to test the safety and efficacy of a novel bioabsorbable hemostatic puncture closure device deployed through an arterial sheath. BACKGROUND. Cardiac catheterization procedures are associated with a risk of complications at the arterial access site. Increasing numbers of interventional procedures requiring large sheaths or intense anticoagulation underline the need for secure, rapid methods of obtaining hemostasis at the time of sheath removal. METHODS. We conducted a randomized, multicenter trial in 435 patients undergoing cardiac catheterization or angioplasty at eight participating centers. In 218 patients, hemostasis was achieved using the device (group I); 217 patients were assigned to the manual pressure control group (group II). RESULTS. There were no significant differences in baseline characteristics. Time to hemostasis was considerably shorter in group I (2.5 +/- 15.2 vs. 15.3 +/- 11.7 min [mean +/- SD], p < 0.0001). The deployment success rate for the device was 96%, and 76% of group I patients experienced immediate (within 1 min) hemostasis. Complication rates were lower in group I for bleeding, hematoma and occurrence of any complication. There was no difference in the small incidence of pseudoaneurysm formation. There was no change in either group in the ankle/brachial systolic blood pressure index. Ultrasound follow-up studies 60 days after device deployment revealed complete absorption of the device in all cases. Subgroup analysis revealed particular benefit in patients undergoing interventional procedures. The administration of heparin was associated with a significantly higher complication rate in the manual pressure control group, whereas heparin had no effect on hemostasis time or complication rates in the device group. CONCLUSIONS. This sheath-deployed, bioabsorbable device provides a safe and effective means of obtaining rapid arterial hemostasis after cardiac catheterization procedures. It appears to be particularly useful in those patients most at risk for access site complications.

This article has been cited by other articles:

				A. Rodriguez and S. G. Katz The Use of the Starclose Device for Obtaining Femoral Artery Hemostasis Vascular and Endovascular Surgery, October 1, 2011; 45(7): 627 - 630. [Abstract] [PDF]

				M. Wanitschek, A. Suessenbacher, J. Dorler, O. Pachinger, N. Moes, and H. Alber Safety and efficacy of femoral artery closure with the FemoSeal(R) device after coronary angiography using a 7 French sheath Perfusion, September 1, 2011; 26(5): 447 - 452. [Abstract] [PDF]

				M. R. Patel, H. Jneid, C. P. Derdeyn, L. W. Klein, G. N. Levine, R. A. Lookstein, C. J. White, Y. Yeghiazarians, K. Rosenfield, and on behalf of the American Heart Association Diagno Arteriotomy Closure Devices for Cardiovascular Procedures: A Scientific Statement From the American Heart Association Circulation, November 2, 2010; 122(18): 1882 - 1893. [Full Text] [PDF]

				T. A. Sanborn, R. Ebrahimi, S. V. Manoukian, B. T. McLaurin, D. A. Cox, F. Feit, M. Hamon, R. Mehran, and G. W. Stone Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial Circ Cardiovasc Interv, February 1, 2010; 3(1): 57 - 62. [Abstract] [Full Text] [PDF]

				S. Bangalore, N. Arora, and F. S. Resnic Vascular Closure Device Failure: Frequency and Implications: A Propensity-Matched Analysis Circ Cardiovasc Interv, December 1, 2009; 2(6): 549 - 556. [Abstract] [Full Text] [PDF]

				W. Mlekusch, E. Minar, P. Dick, S. Sabeti, A. Bartok, M. Haumer, M. Bonelli, L. Vormittag, R. Koppensteiner, and M. Schillinger Access Site Management after Peripheral Percutaneous Transluminal Procedures: Neptune Pad Compared with Conventional Manual Compression Radiology, December 1, 2008; 249(3): 1058 - 1063. [Abstract] [Full Text] [PDF]

				A. Kadner, J. Schmidli, I. Schwegler, F. Dick, F. Schonhoff, T. Carrel, and H. Savolainen Complications Associated With the Arterial Puncture Closure Device--Angio-Seal Vascular and Endovascular Surgery, June 1, 2008; 42(3): 225 - 227. [Abstract] [PDF]

				I. Malik Closure devices for femoral punctures Heart, May 1, 2008; 94(5): 547 - 548. [Full Text] [PDF]

				V. R. Kalapatapu, A. T. Ali, F. Masroor, M. M. Moursi, and J. F. Eidt Techniques for Managing Complications of Arterial Closure Devices Vascular and Endovascular Surgery, October 1, 2006; 40(5): 399 - 408. [Abstract] [PDF]

				E. Nikolsky, R. Mehran, A. Halkin, E. D. Aymong, G. S. Mintz, Z. Lasic, M. Negoita, M. Fahy, S. Krieger, I. Moussa, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: A meta-analysis J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1200 - 1209. [Abstract] [Full Text] [PDF]

				M. Koreny, E. Riedmuller, M. Nikfardjam, P. Siostrzonek, and M. Mullner Arterial Puncture Closing Devices Compared With Standard Manual Compression After Cardiac Catheterization: Systematic Review and Meta-analysis JAMA, January 21, 2004; 291(3): 350 - 357. [Abstract] [Full Text] [PDF]

				G. N. Levine, M. J. Kern, P. B. Berger, D. L. Brown, L. W. Klein, D. J. Kereiakes, T. A. Sanborn, A. K. Jacobs, and for the American Heart Association Diagnostic and Management of Patients Undergoing Percutaneous Coronary Revascularization Ann Intern Med, July 15, 2003; 139(2): 123 - 136. [Abstract] [Full Text] [PDF]

				M. A. Funovics, F. Wolf, M. O. Philipp, S. Kee, B. Tichy, A. Dirisamer, T. Rand, and J. Lammer Feasibility Study of NeoMend, a Percutaneous Arterial Closure Device That Uses a Nonthrombogenic Bioadhesive Am. J. Roentgenol., February 1, 2003; 180(2): 533 - 538. [Abstract] [Full Text] [PDF]

				T. Jones and H. McCutcheon Effectiveness of Mechanical Compression Devices in Attaining Hemostasis After Femoral Sheath Removal Am. J. Crit. Care., March 1, 2002; 11(2): 155 - 162. [Abstract] [Full Text] [PDF]

				S. L. Meyerson, T. Feldman, T. R. Desai, J. Leef, L. B. Schwartz, and J. F. Mckinsey Anglographic Access Site Complications in the Era of Arterial Closure Devices Vascular and Endovascular Surgery, March 1, 2002; 36(2): 137 - 144. [Abstract] [PDF]

				G. Dangas, R. Mehran, S. Kokolis, D. Feldman, L. F. Satler, A. D. Pichard, K. M. Kent, A. J. Lansky, G. W. Stone, and M. B. Leon Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices J. Am. Coll. Cardiol., September 1, 2001; 38(3): 638 - 641. [Abstract] [Full Text] [PDF]

				D. Tavris, T. Gross, B. Gallauresi, and L. Kessler Arteriotomy closure devices--the FDA perspective J. Am. Coll. Cardiol., September 1, 2001; 38(3): 642 - 644. [Full Text] [PDF]

				T. M. Bashore, E. R. Bates, P. B. Berger, D. A. Clark, J. T. Cusma, G. J. Dehmer, M. J. Kern, W. K. Laskey, M. P. O'Laughlin, S. Oesterle, et al. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on Cardiac Catheterization Laboratory Standards: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents endorsed by the American Heart Association and the Diagnostic and Interventional Catheterization Committee of the Council on Clinical Cardiology of the AHA J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2170 - 2214. [Full Text] [PDF]

				S. L. Tan Explantation of Infected Hemostatic Puncture Closure Devices: A Case Report Vascular and Endovascular Surgery, September 1, 1999; 33(5): 507 - 510. [Abstract] [PDF]

				K T Koch, J J Piek, R J de Winter, K Mulder, C E Schotborgh, J G P Tijssen, and K I Lie Two hour ambulation after coronary angioplasty and stenting with 6 F guiding catheters and low dose heparin Heart, January 1, 1999; 81(1): 53 - 56. [Abstract] [Full Text]

				S. H. Duda, J. Wiskirchen, M. Erb, U. Schott, K. Khaligi, P. L. Pereira, J. Albes, and C. D. Claussen Suture-mediated Percutaneous Closure of Antegrade Femoral Arterial Access Sites in Patients Who Have Full Anticoagulation Therapy Radiology, January 1, 1999; 210(1): 47 - 52. [Abstract] [Full Text]

				R. R. Azar, R. G. McKay, P. D. Thompson, J. A. Hirst, J. F. Mitchell, D. B. Fram, D. D. Waters, and F. J. Kiernan Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1996 - 2002. [Abstract] [Full Text] [PDF]